Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL

Clinical trial NCT04354402 · COMPLETED

Trial details

NCT number: NCT04354402
Sponsor: SymBio Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma

Start date: 2020-03-26
Primary completion: 2020-11-11
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.